1 of 1
Story summary
- Apollo Global Management is in talks to acquire Johnson & Johnson’s DePuy Synthes orthopedics unit.
- The deal could value DePuy Synthes at roughly $20 billion.
- DePuy Synthes reported $9.3 billion in sales for 2025.
- J&J CFO Joe Wolk said the company is evaluating separation options and aims for a mid-2027 spin-off.
- Apollo shares rose 0.8% to $128.98 after the acquisition talks began.